CELSENTRI var genstand for to hovedundersøgelser, hvori der deltog i alt 1 076 patienter med CCR5- tropisk hiv- infektion.
CELSENTRI was studied in two main studies involving a total of 1,076 patients with CCR5-tropic HIV infection.